Radiopharm Theranostics Files 6-K Report
Ticker: RDPTF · Form: 6-K · Filed: May 12, 2025 · CIK: 1949257
| Field | Detail |
|---|---|
| Company | Radiopharm Theranostics Ltd (RDPTF) |
| Form Type | 6-K |
| Filed Date | May 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, foreign-private-issuer, administrative
TL;DR
Radiopharm Theranostics filed a 6-K on 5/12/25, confirming 20-F reporting for foreign private issuers.
AI Summary
Radiopharm Theranostics Limited filed a Form 6-K on May 12, 2025, reporting information for the month of May 2025. The filing indicates the company is a foreign private issuer and will file its annual reports under Form 20-F. The company's principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
Why It Matters
This filing provides routine updates for investors and the SEC regarding Radiopharm Theranostics' status as a foreign private issuer and its reporting obligations.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not contain new material financial or operational information.
Key Players & Entities
- Radiopharm Theranostics Limited (company) — Registrant
- 001-41621 (company) — SEC File Number
- Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (company) — Principal executive office address
- Form 20-F (company) — Annual report form
- May 2025 (date) — Reporting period
- May 12, 2025 (date) — Filing date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information to the SEC.
Which annual report form does Radiopharm Theranostics Limited file?
Radiopharm Theranostics Limited files its annual reports under cover of Form 20-F.
What is the filing date of this Form 6-K?
This Form 6-K was filed on May 12, 2025.
Where is Radiopharm Theranostics Limited's principal executive office located?
The company's principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
Is Radiopharm Theranostics Limited furnishing information under Rule 12g3-2(b)?
No, the filing indicates 'No' for furnishing information pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 12, 2025 regarding Radiopharm Theranostics Ltd (RDPTF).